Vanushka P.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- Noninferiority of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide versus beclometasone dipropionate/formoterol fumarate in asthma
- Safety Evaluation of CHF5993 pMDI Formulated with HFA-152a Versus HFA-134a in Moderate to Severe Asthma Patients
- Efficacy and Safety Evaluation of Atuliflapon in Adults with Moderate-to-Severe Uncontrolled Asthma: A Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 158 of 561 partner sites.
Specializations
Severe Asthma Management
This investigator specializes in treating severe eosinophilic asthma, conducting research into novel therapeutic approaches for patients with challenging respiratory conditions. Their work includes evaluation of dexpramipexole as an innovative treatment option for severe asthma cases.
- Eosinophilic Inflammation Control
- Long-term Asthma Management
- Severe Exacerbation Prevention
Respiratory Drug Delivery Systems
The investigator focuses on advancing inhaler technology and delivery systems, particularly studying new propellant formulations and their effects on respiratory treatment efficacy. Their research encompasses evaluation of various metered-dose inhaler technologies.
- Novel Propellant Development
- Inhaler Device Innovation
- Bronchodilator Delivery Systems
Pulmonary Disease Treatment
Their expertise extends to chronic obstructive pulmonary disease (COPD) management, investigating combination therapies including triple therapy approaches. The research focuses on cardiopulmonary outcomes and innovative treatment modalities.
- Combined Therapeutic Approaches
- Cardiopulmonary Outcomes
- Bronchodilator Therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.